This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gloviczki, P. Search for Related Content PubMed PubMed Citation Articles by Gloviczki, P. Pubmed/NCBI databases Medline Plus Health Information Endoscopy Social Bookmarking                         What's this?

Subfascial endoscopic perforator vein surgery: indications and results

Professor of Surgery, Mayo Medical School, Vice-chair, Division of Vascular Surgery, Mayo Clinic and Foundation, Rochester, MN, USA

Subfascial endoscopic perforator surgery (SEPS) is a new, minimally invasive technique performed in patients with advanced chronic venous insufficiency. The objective of the operation is to interrupt incompetent medial calf perforating veins to decrease venous reflux and reduce ambulatory venous hypertension in critical areas above the ankle where venous ulcers most frequently develop. Patients with stasis skin changes and healed or active venous ulcerations are potential candidates for the operation. Preoperative evaluation is performed with duplex scanning of the superficial, deep and perforator system, to diagnose both obstruction and valvular incompetence. Results of the North American SEPS Registry (NASEPS) as well as experience in several individual centers confirmed that the operation has significantly fewer wound complications than the classic open surgical techniques, and that rapid ulcer healing can be achieved. At the Mayo Clinic an ulcer recurrence rate of 12% was observed, with recurrence significantly more frequent in post-thrombotic limbs than in patients with primary venous valvular incompetence. The NASEPS Registry report confirmed a 2-year cumulative ulcer recurrence rate of 28%; ulcer recurrence was significantly more frequent in post-thrombotic limbs, especially in those with deep venous obstruction.

SEPS is a new, low-risk, outpatient procedure that effectively decreases perforator reflux in patients with venous ulcerations, and should be added to our armamentarium to treat patients with advanced chronic venous disease. Long-term prospective and randomized studies are, however, still required to provide level I evidence of late efficacy.

Key Words: endoscopic surgery • perforator veins • venous ulcers

Vascular Medicine, Vol. 4, No. 3, 173-180 (1999)
DOI: 10.1177/1358836X9900400308


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T Luebke and J Brunkwall Meta-analysis of subfascial endoscopic perforator vein surgery (SEPS) for chronic venous insufficiency Phlebology, February 1, 2009; 24(1): 8 - 16. [Abstract] [Full Text] [PDF]

				N. Labropoulos, P. J. Patel, J. E. Tiongson, L. Pryor, L. R. Leon Jr, and A. K. Tassiopoulos Patterns of Venous Reflux and Obstruction in Patients With Skin Damage Due to Chronic Venous Disease Vascular and Endovascular Surgery, February 1, 2007; 41(1): 33 - 40. [Abstract] [PDF]